Type I interferons in tolerance in the steady state

NIH RePORTER · NIH · P01 · $371,739 · view on reporter.nih.gov ↗

Abstract

Summary Type I interferons are a powerful cytokine family that play an essential role in innate immune protection from viruses. In addition to their direct anti-viral activities, they strongly activate multiple cells of the adaptive immune system, including APC, B cells, and T cells. Interestingly, interferons are expressed in the thymus in the steady state, in the absence of infections. In this project, we propose to systematically define the role that thymic type I interferon plays in immunological self-tolerance. We hypothesize that type I interferons are critical to promote tolerance to self-epitopes that are usually only displayed during infections. Aim 1 will determine what stimuli promote thymic medullary epithelial cells to produce IFNb. Aim 2 will determine the consequences of IFNb expression on tolerance to conventional and inflammation induced self antigens. Aim 3 will determine if autoimmunity results in the absence of thymic IFNb, particularly when mice are challenged by infections.

Key facts

NIH application ID
9994826
Project number
5P01AI035296-26
Recipient
UNIVERSITY OF MINNESOTA
Principal Investigator
Kristin A. Hogquist
Activity code
P01
Funding institute
NIH
Fiscal year
2020
Award amount
$371,739
Award type
5
Project period
1997-09-15 → 2024-08-31